Patent ID: 11958862
Assignee: PGI DRUG DISCOVERY LLC
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 30:
31. The method according to claim 29, wherein said symptom is selected from a decline in cognitive functions or cognitive domains, deficits in attention, disorganized thinking, slow thinking, difficulty in understanding, poor concentration, impairment of problem solving, poor memory, difficulties in expressing thoughts; difficulties in integrating thoughts, feelings and behavior; difficulties in extinction of irrelevant thoughts, deficit in dopamine signaling, tremors, dyskinesia, dystonia, tics, dysphonia, ataxia, myoclonus, bipolar disorder, seasonal affective disorder; cognitive deficit, sleep related disorder, sleep disorder produced by psychiatric conditions, chronic fatigue syndrome, anxieties, obsessive compulsive disorder, post-menopausal vasomotor symptoms, neurodegenerative disease, manic disorder, dysthymic disorder, obesity, senile dementia, Early Onset Alzheimer's Disease, Alzheimer's type dementia, cognition, memory loss, amnesia/amnestic syndrome, disturbances of consciousness, coma, lowering of attention, speech disorder, agnosia, aphasia, apraxia, Mild Cognitive Impairment (MCI), benign forgetfulness, mild neurocognitive disorder, major neurocognitive disorder, neurocognitive disorder due to disease, Binswanger's Disease (subcortical leukoencephalopathy), Capgras Syndrome, pain, migraine or migraine headache, sexual dysfunction, nighttime sleep disturbance/sleep fragmentation associated with narcolepsy or other conditions; sleep paralysis associated with narcolepsy or other conditions; hypnagogic and hypnapompic hallucinations associated with narcolepsy or other conditions; excessive daytime sleepiness associated with narcolepsy, sleep apnea or shift work disorder and other medical conditions; akinesias, akinetic-rigid syndromes, dyskinesias, dystonias, epilepsy, seizures, apathy, depression, cognitive impairment, psychosis, aggression, agitation, poor impulse control and sleep disruptions; disturbances in perception, thought content, mood, or behaviors, elevated or irritable mood, hyperactivity, grandiosity, decreased need for sleep, racing thoughts and psychosis, anhedonia, sad mood, hopelessness, poor self-esteem, diminished concentration, lethargy, phasic progression and development, deterioration in social behavior and professional capability, psychotic symptoms, disorders of thought content, disorders of mentality; disorders of perceptibility, emotions, self-perceptions, intentions, impulses, and/or inter-human relationships; psychomotoric disorders, fear, worry, uneasiness, avoidance behavior, cognitive ideation, depressed mood (sadness), poor concentration, insomnia, fatigue, appetite disturbances, excessive guilt, and thoughts of suicide.